1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Fasciitis Global Clinical Trials Review, H2, 2015

Fasciitis Global Clinical Trials Review, H2, 2015

  • October 2015
  • -
  • GlobalData
  • -
  • 55 pages

Fasciitis Global Clinical Trials Review, H2, 2015

Summary

GlobalData's clinical trial report, “Fasciitis Global Clinical Trials Review, H2, 2015" provides an overview of Fasciitis clinical trials scenario. This report provides top line data relating to the clinical trials on Fasciitis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table Of Contents

Fasciitis Global Clinical Trials Review, H2, 2015
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Countries Contributing to Clinical Trials in Asia-Pacific 9
Top Five Countries Contributing to Clinical Trials in Europe 10
Top Countries Contributing to Clinical Trials in North America 11
Top Countries Contributing to Clinical Trials in Middle East and Africa 12
Top Countries Contributing to Clinical Trials in Central and South America 13
Clinical Trials by G7 Countries: Proportion of Fasciitis to Musculoskeletal Clinical Trials 14
Clinical Trials by Phase in G7 Countries 15
Clinical Trials in G7 Countries by Trial Status 16
Clinical Trials by E7 Countries: Proportion of Fasciitis to Musculoskeletal Clinical Trials 17
Clinical Trials by Phase in E7 Countries 18
Clinical Trials in E7 Countries by Trial Status 19
Clinical Trials by Phase 20
In Progress Trials by Phase 21
Clinical Trials by Trial Status 22
Clinical Trials by End Point Status 23
Subjects Recruited Over a Period of Time 24
Clinical Trials by Sponsor Type 25
Prominent Sponsors 26
Top Companies Participating in Fasciitis Therapeutics Clinical Trials 28
Prominent Drugs 30
Clinical Trial Profile Snapshots 31
Appendix 52
Abbreviations 52
Definitions 52
Research Methodology 53
Secondary Research 53
About GlobalData 54
Contact Us 54
Disclaimer 54
Source 55

List of Tables
Fasciitis Therapeutics, Global, Clinical Trials by Region, 2015* 6
Fasciitis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 7
Fasciitis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 8
Fasciitis Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2015* 9
Fasciitis Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 10
Fasciitis Therapeutics Clinical Trials, North America, Top Countries, 2015* 11
Fasciitis Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015* 12
Fasciitis Therapeutics Clinical Trials, Central and South America, Top Countries, 2015* 13
Proportion of Fasciitis to Musculoskeletal Clinical Trials, G7 Countries (%), 2015* 14
Fasciitis Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 15
Fasciitis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 16
Proportion of Fasciitis to Musculoskeletal Clinical Trials, E7 Countries (%), 2015* 17
Fasciitis Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 18
Fasciitis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 19
Fasciitis Therapeutics, Global, Clinical Trials by Phase, 2015* 20
Fasciitis Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 21
Fasciitis Therapeutics, Global, Clinical Trials by Trial Status, 2015* 22
Fasciitis Therapeutics Clinical Trials, Global, by End Point Status, 2015* 23
Fasciitis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 24
Fasciitis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 25
Fasciitis Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 27
Fasciitis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 29
Fasciitis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 30

List of Figures
Fasciitis Therapeutics, Global, Clinical Trials by Region (%), 2015* 6
Fasciitis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 7
Fasciitis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 8
Fasciitis Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2015* 9
Fasciitis Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 10
Fasciitis Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 11
Fasciitis Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2015* 12
Proportion of Fasciitis to Musculoskeletal Clinical Trials, G7 Countries (%), 2015* 14
Fasciitis Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 15
Fasciitis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 16
Proportion of Fasciitis to Musculoskeletal Clinical Trials, E7 Countries (%), 2015* 17
Fasciitis Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 18
Fasciitis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 19
Fasciitis Therapeutics, Global, Clinical Trials by Phase (%), 2015* 20
Fasciitis Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 21
Fasciitis Therapeutics, Global, Clinical Trials by Trial Status, 2015* 22
Fasciitis Therapeutics Clinical Trials, Global, by End Point Status, 2015* 23
Fasciitis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 24
Fasciitis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 25
Fasciitis Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 26
Fasciitis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 28
Fasciitis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 30
GlobalData Methodology 53

Companies Mentioned
Kaken Pharmaceutical Co., Ltd.
Seikagaku Corporation
F. Hoffmann-La Roche Ltd.
Merz Pharmaceuticals GmbH
Kolding Sygehus
Ipsen S.A.
Atox Bio Inc.
Arthrex, Inc.

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
OpportunityAnalyzer: Hyperparathyroidism - Opportunity Analysis and Forecasts to 2025

OpportunityAnalyzer: Hyperparathyroidism - Opportunity Analysis and Forecasts to 2025

  • $ 10995
  • Industry report
  • December 2016
  • by GlobalData

OpportunityAnalyzer: Hyperparathyroidism - Opportunity Analysis and Forecasts to 2025 Summary Hyperparathyroidism (HPT) is a common endocrinal disorder characterized by excessive plasma levels of parathyroid ...

PharmaPoint: HER2-Negative/HR+ and Triple Negative Breast Cancer - Global Drug Forecast and Market Analysis to 2025

PharmaPoint: HER2-Negative/HR+ and Triple Negative Breast Cancer - Global Drug Forecast and Market Analysis to 2025

  • $ 10995
  • Industry report
  • December 2016
  • by GlobalData

PharmaPoint: HER2-Negative/HR+ and Triple Negative Breast Cancer - Global Drug Forecast and Market Analysis to 2025 Summary Human Epidermal growth factor Receptor type 2 (HER2-) breast cancer is the second ...

PharmaPoint: Hepatitis C Virus (HCV) Therapeutics - Global Drug Forecast and Market Analysis to 2025

PharmaPoint: Hepatitis C Virus (HCV) Therapeutics - Global Drug Forecast and Market Analysis to 2025

  • $ 10995
  • Industry report
  • December 2016
  • by GlobalData

PharmaPoint: Hepatitis C Virus (HCV) Therapeutics - Global Drug Forecast and Market Analysis to 2025 Summary Hepatitis C virus (HCV) is a small, enveloped RNA virus that causes acute and chronic infections ...


Download Unlimited Documents from Trusted Public Sources

Therapy Market and Cardiovascular Disease Statistics in the US

  • March 2017
    30 pages
  • Therapy  

    Cardiovascular ...  

    Cholesterol  

  • United States  

View report >

Therapy Market in the UK

  • March 2017
    50 pages
  • Therapy  

    Opioid  

  • United Kingdom  

    Europe  

View report >

Insulin Market and Diabetes Statistics in the US

  • March 2017
    8 pages
  • Insulin  

    Antidiabetics  

    Diabetes  

  • United States  

View report >

Diabetes Statistics

2 days ago

Related Market Segments :

Therapy

ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.